ArticleBrain sciences2021
Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort.
Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 25 citations in OpenAlex.
- Factors Impacting the Telephone Follow-Up Response Rate in Patients With Migraine Without Aura: A Cross-Sectional Study of 1299 Females.Pain research & management · 2026Article
- Patterns of Past COVID-19 and EBV Infection in Primary Headache Disorders: A Population Study.Brain and behavior · 2025Article
- The Impact of COVID-19 on Migraine: The Patients' Perspective.Life (Basel, Switzerland) · 2024Article
- Psychiatric Comorbidities and Quality of Life in Patients with Vestibular Migraine and Migraine without Vertigo: A Cross-Sectional Study from a Tertiary Clinic.Audiology research · 2024Article
- Article
- New-onset headache following COVID-19: An Italian multicentre case series.Journal of the neurological sciences · 2023Article
- Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic.Brain sciences · 2023Article
- Reply to correspondence "Contributing factors towards progression of migraines during the Covid-19 pandemic".Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022Article
- Transient global amnesia after COVID-19: A systematic scoping review of case reports.Current journal of neurology · 2022Article
- Impact of COVID-19 on chronic pain structures: data from French national survey.Journal of comparative effectiveness research · 2022Article
- Indomethacin for refractory COVID or post-COVID headache: a retrospective study.Acta neurologica Belgica · 2022Observational
- The impacts of masks and disinfectants on migraine patients in the COVID-19 pandemic.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022Article
- Prevalence and impact of migraine among university students in Bangladesh: findings from a cross-sectional survey.BMC neurology · 2022Article
- An Internet-based study on the impact of COVID-19 pandemic-related lockdown on migraine in India.Acta neurologica Scandinavica · 2021Article
- Internet hospital response to the COVID-19 pandemic in a tertiary hospital in China: Perspectives based on a mixed-methods.Digital healthArticle
- Can COVID-19 pandemic worsen previous neurological/psychiatric diseases?Neurology perspectivesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe study aims to assess the impact of the second COVID-19 pandemic wave on migraine characteristics.
methodsThis is an observational cross-sectional study conducted on migraine patients previously interviewed during the first Italian pandemic outbreak. A second structured telephone interview was conducted between 20 November 2020 and 18 January 2021. We compared migraine characteristics among T0 (before pandemic), T1 (during the first pandemic phase), and T2 (during the second pandemic phase).
resultsAmong the 433 patients interviewed during the first pandemic phase, 304 cases were finally considered. One hundred forty-eight patients had a control visit between March 2020 and December 2020, 120 had an in-person visit, 14 by phone, the remainder used telemedicine software provided by the hospital. Frequency of headache, number of symptomatic drugs and headache intensity worsened during T2, compared to T0 and T1, especially in episodic migraine. Headache intensity increased relating to the negative emotional impact of the pandemic. Migraine management during the pandemic did not influence the clinical outcome.
conclusionThe prolongation of the pandemic seems to have a negative impact on migraine evolution. The arousal and negative psychological behavior toward the COVID-19 outbreak seem to worsen migraine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.